![](https://futurehealthstocks.com/wp-content/uploads/2025/02/AdobeStock_419260749_Editorial_Use_Only-1024x576-1.jpeg)
BioTech
NIH resumes grant reviews after two-week pause, along with some communications and travel
On Tuesday morning, the National Institutes of Health hosted the first study section to review grant applications in over two weeks, following an abrupt and